Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
First Pan-African neuroscience journal gets ready to launch
With lower-than-average article processing fees, and issues dedicated to topics important to the continent, the journal hopes to give African neuroscience research much-needed international visibility.
First Pan-African neuroscience journal gets ready to launch
With lower-than-average article processing fees, and issues dedicated to topics important to the continent, the journal hopes to give African neuroscience research much-needed international visibility.
By
Lauren Schenkman
28 October 2025 | 5 min listen
New method identifies two-hit genetic variation in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 27 October.
New method identifies two-hit genetic variation in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 27 October.
By
Jill Adams
28 October 2025 | 2 min read
The missing half of the neurodynamical systems theory
Bifurcations—an underexplored concept in neuroscience—can help explain how small differences in neural circuits give rise to entirely novel functions.
The missing half of the neurodynamical systems theory
Bifurcations—an underexplored concept in neuroscience—can help explain how small differences in neural circuits give rise to entirely novel functions.
By
Xiao-Jing Wang
27 October 2025 | 9 min listen